FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4511611000001106: Razoxane 125mg tablets (Unichem Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17785501000001117 Razoxane 125mg tablets (Unichem Plc) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54430201000001113 Razoxane 125mg tablets (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Razoxane 125mg tablets (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Is a Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has active ingredient Cytoprotective agent false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has active ingredient Antidote false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has active ingredient Razoxane false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has specific active ingredient Razoxane true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Razoxane 125mg tablets (Unichem Plc) 30 tablet Is pack of False Razoxane 125mg tablets (Unichem Plc) Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (Unichem Plc) 30 tablet Has AMP True Razoxane 125mg tablets (Unichem Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start